Treatment of HIV-associated wasting with recombinant human growth hormone: monitoring of body composition changes by bioelectrical impedance analysis (BIA).

European journal of medical research

Volumn 7, Issue 3, 2002, Pages 103-108

  Jager H ^a   Knechten, H ^a   Moll, A ^a   Weitner, L ^a   Fischer, H ^a   Schmitt Rau, K ^a  

^a Kuratorium für Immunschwäche KIS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMPEDANCE; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; WASTING SYNDROME; WEIGHT GAIN;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; ELECTRIC IMPEDANCE; FEMALE; GROWTH HORMONE; HIV WASTING SYNDROME; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; WEIGHT GAIN;

EID: 0037187923     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)